Quarterly Sales
Net sales of $792 million in Q1 FY2026, driven by strength across consumer solutions despite regional headwinds.
Adjusted EBITDA and Guidance
Adjusted EBITDA of $93 million for the quarter (flat year-over-year on a constant currency basis). Management reaffirmed full-year 2026 adjusted EBITDA guidance targeting ~9% growth.
Rest of World Earnings Improvement
Rest of World adjusted EBITDA increased 9% year-over-year to $35 million, reflecting disciplined cost management and synergy realization despite revenue declines in Europe.
Americas Volume Growth
Americas delivered 2% organic volume growth in the quarter, led by wipes and adult end markets (wipes benefited from elevated flu season demand).
Project CORE and Synergy Progress
Project CORE transformation tracking as planned; expected benefit in the range of $15–$20 million from CORE initiatives. Management expects $25 million of synergy realization in 2026 toward a $55 million total synergy target.
Strong Cash Generation and Liquidity
Free cash flow of $97 million over the last four quarters (approximate free cash flow yield ~18% based on market cap). Available liquidity of about $550 million at quarter-end.
Debt Reduction and Capital Allocation
Repaid $27 million of debt in the quarter and expects to repay approximately $100 million over the fiscal year; disciplined capital allocation and deleveraging target of ~3x leverage ratio.
Notable Product and Technology Innovations
Launched PFAS-free barrier protection for healthcare applications, advanced battery materials candidate for government grant, and expanded Kamisoft (softness platform) with $15 million sales last year and mid-single-digit growth into 2026; innovation margins expected above the corporate average (~11%), often mid-teens to 20%+.
Portfolio and Commercial Wins
Strong performance in premium private-label baby and disinfectant wipes, gains from branded Geca Tape in energy and cable applications, and infrastructure-driven growth in Europe from utility and data-cable spending.